Inactive Instrument

Mesco Pharmaceuticals Limited

Equities

500274

INE839X01015

Mesco Pharmaceuticals Limited Announces Demise of Jitendra Kumar Singh, Non-Executive and Non Independent Director

September 09, 2019 at 04:31 am

Mesco Pharmaceuticals Limited intimated the demise of Mr. Jitendra Kumar Singh, Non-Executive and Non Independent Director on 05th September, 2019. Mr. Jitendra Kumar Singh was the founder promoter of Mesco Group.

Latest news about Mesco Pharmaceuticals Limited

Mesco Pharmaceuticals Widens Net Loss in Fiscal Q3	22-02-17	MT
Mesco Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	22-02-17	CI
Mesco Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021	21-11-12	CI
Mesco Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2021	21-07-01	CI
Mesco Pharmaceuticals Limited Announces Resignation of Savita Sethi as Independent Director	21-03-09	CI
Mesco Pharmaceuticals Limited Reports Earnings Results for the Third Quarter Ended December 31, 2020	21-02-13	CI
Mesco Pharmaceuticals Limited Reports Earnings Results for the Second Quarter Ended September 30, 2020	20-11-12	CI
Mesco Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2020	20-07-31	CI
Mesco Pharmaceuticals Limited Appoints Dhruv Singh as Chief Executive Officer	20-07-31	CI
Mesco Pharmaceuticals Limited Appoints Dhruv Singh as an Additional Director on the Board of the Company	20-07-31	CI
Mesco Pharmaceuticals Limited Reports Earnings Results for the Third Quarter Ended December 31, 2019	20-02-13	CI
Mesco Pharmaceuticals Limited Reports Earnings Results for the Second Quarter Ended September 30, 2019	19-11-15	CI
Mesco Pharmaceuticals Limited Announces Demise of Jitendra Kumar Singh, Non-Executive and Non Independent Director	19-09-09	CI
Mesco Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2019	19-08-13	CI
Mesco Pharmaceuticals Limited Appoints Hawa Singh Chahar as an Additional Director (Non-Executive Independent Director)	19-06-21	CI
Mesco Pharmaceuticals Limited Announces Audited Standalone Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2019	19-05-28	CI
Mesco Pharmaceuticals Limited Appoints Varinder Prakash as an Additional Director	19-05-28	CI
Mesco Pharmaceuticals Announces Management Changes	19-04-27	CI
Mesco Pharmaceuticals Limited Announces Resignation of Subash Chander Seth as Non-Executive, Independent Director	19-04-01	CI
Mesco Pharmaceuticals Limited Announces Change in Management	19-03-25	CI
Mesco Pharmaceuticals Limited Reports Unaudited Earnings Results for the Quarter and Nine Months Ended December 31, 2018	19-02-13	CI
Mesco Pharmaceuticals Ltd. Reports Unaudited Earnings Results for the Second Quarter and Six Months Ended September 30, 2018	18-11-14	CI
Mesco Pharmaceuticals Ltd Reports Unaudited Earnings Results for the First Quarter Ended June 30, 2018	18-08-14	CI
Mesco Pharmaceuticals Ltd Reports Audited Standalone Earnings Results for the Fourth Quarter and Year Ended March 31, 2018	18-05-30	CI
Mesco Pharmaceuticals Ltd Announces Management Changes	18-04-03	CI

Chart Mesco Pharmaceuticals Limited

Duration

Period

More charts

Company Profile

Sector

More about the company